Alphabet Inc.

Holdings History for Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

Symbol: SPRO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.08%	0%	$2,073,651	889,979	0		$2.33	Q4 2025
30 Sep 2025	0.07%	0%	$1,673,161	889,979	0		$1.88	Q3 2025
30 Jun 2025	0.12%	0%	$2,580,939	889,979	0		$2.90	Q2 2025
31 Mar 2025	0.04%	0%	$640,785	889,979	0		$0.72	Q1 2025
31 Dec 2024	0.05%	0%	$916,678	889,979	0		$1.03	Q4 2024
30 Sep 2024	0.06%	0%	$1,192,572	889,979	0		$1.34	Q3 2024
30 Jun 2024	0.06%	0%	$1,156,973	889,979	0		$1.30	Q2 2024
31 Mar 2024	0.06%	0%	$1,530,763	889,979	0		$1.72	Q1 2024
31 Dec 2023	0.06%	0%	$1,308,269	889,979	0		$1.47	Q4 2023
30 Sep 2023	0.07%	0%	$1,076,874	889,979	0		$1.21	Q3 2023
30 Jun 2023	0.07%	0%	$1,290,469	889,979	0		$1.45	Q2 2023
31 Mar 2023	0.07%	0%	$1,290,470	889,979	0		$1.45	Q1 2023
31 Dec 2022	0.09%	0%	$1,539,664	889,979	0		$1.73	Q4 2022
30 Sep 2022	0.09%	0%	$1,780,000	889,979	0		$2.00	Q3 2022
30 Jun 2022	0.04%	0%	$659,000	889,979	0		$0.74	Q2 2022
31 Mar 2022	0.25%	0%	$7,743,000	889,979	0		$8.70	Q1 2022
31 Dec 2021	0.34%	0%	$14,249,000	889,979	0		$16.01	Q4 2021
30 Sep 2021	0.39%	0%	$16,385,000	889,979	0		$18.41	Q3 2021
30 Jun 2021	0.25%	0%	$12,424,000	889,979	0		$13.96	Q2 2021
31 Mar 2021	0.53%	0%	$13,100,000	889,979	0		$14.72	Q1 2021
31 Dec 2020	0.83%	-0.21%	$17,257,000	889,979	-222,494	-20%	$19.39	Q4 2020
30 Sep 2020	0.58%	0%	$12,415,000	1,112,473	0		$11.16	Q3 2020
30 Jun 2020	0.69%	0%	$15,052,000	1,112,473	0		$13.53	Q2 2020
31 Mar 2020	0.59%	0%	$8,989,000	1,112,473	0		$8.08	Q1 2020
31 Dec 2019	0.65%	0%	$10,696,000	1,112,473	0		$9.61	Q4 2019
30 Sep 2019	0.35%	0%	$11,792,000	1,112,473	0		$10.60	Q3 2019
30 Jun 2019	0.24%	0%	$12,805,000	1,112,473	0		$11.51	Q2 2019
31 Mar 2019	0.74%	0%	$14,251,000	1,112,473	0		$12.81	Q1 2019
31 Dec 2018	0.81%	0%	$6,842,000	1,112,473	0		$6.15	Q4 2018
30 Sep 2018	1.1%	0%	$11,692,000	1,112,473	0		$10.51	Q3 2018
30 Jun 2018	1.4%	0%	$16,320,000	1,112,473	0		$14.67	Q2 2018
31 Mar 2018	2.9%	0%	$15,853,000	1,112,473	0		$14.25	Q1 2018
31 Dec 2017	3.9%	+3.9%	$13,072,000	1,112,473	+1,112,473	NEW	$11.75	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.